Screening Value of the I‐Douleur Neuropathique 4 Questionnaire for Small Fibre Neuropathy in Patients With Painful Syndromes: Insights From 872 Skin Biopsies
European Journal of Neurology · 2026
DOI: 10.1111/ene.70499 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, 2026. Verfasst von Simon Frachet und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, University Hospital of Limoges, Limoges, France. Hauptthemen laut MEDLINE: Small Fiber Neuropathy, Skin, Neuralgia. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Small‐fibre neuropathy (SFN), which is defined by the sole involvement of small sensory fibres, often leads to neuropathic pain. The diagnosis of SFN relies on clinical, neurophysiologic, and morphologic abnormalities. A decrease in intraepidermal nerve fibre density (IENFD) on a skin biopsy specimen is considered useful in the diagnosis of SFN in the appropriate clinical context. The self‐administered Douleur Neuropathique 4 (I‐DN4) questionnaire, designed to differentiate neuropathic from somatic pain, shows high sensitivity and specificity but has not been specifically investigated with regard to SFN.
Methods
This retrospective study examined the diagnostic accuracy of I‐DN4 for SFN in 872 patients who were systematically assessed at the time of skin biopsy according to local standards of routine care, after excluding central nervous system diseases and other peripheral nerve disorders by careful clinical examination and medical history.
Results
An I‐DN4 score of ≥ 3 had a sensitivity of 93% and a specificity of 18.13% for diagnosing SFN. ROC analysis revealed an AUC of 0.53, indicating no discriminative ability for this condition. There were no correlations between the I‐DN4 scores and the adjusted IENFD or proximo‐distal IENFD ratio. Only the sensation of burning was a moderate predictor of SFN risk (odds ratio [OR] = 1.65; 95% confidence interval [CI], 1.04–2.68; p = 0.038). Hypoesthesia to pinprick was also associated with a moderate risk of a reduced IENFD at the distal leg (OR = 1.52; 95% CI, 1.03–2.25; p = 0.040).
Conclusions
I‐DN4 is not an effective standalone tool for screening SFN in patients with painful syndromes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neurology Department, University Hospital of Limoges, Limoges, France.
- UR20218-NEURIT, University of Limoges, Limoges, France.
ORCID-Profile: Simon Frachet
Zitieren
APA
Frachet, S., Soust, E., Richard, L., Danigo, A., Demiot, C., & Magy, L. (2026). Screening Value of the I‐Douleur Neuropathique 4 Questionnaire for Small Fibre Neuropathy in Patients With Painful Syndromes: Insights From 872 Skin Biopsies. European Journal of Neurology. https://doi.org/10.1111/ene.70499
Vancouver
Frachet S, Soust E, Richard L, Danigo A, Demiot C, Magy L. Screening Value of the I‐Douleur Neuropathique 4 Questionnaire for Small Fibre Neuropathy in Patients With Painful Syndromes: Insights From 872 Skin Biopsies. European Journal of Neurology. 2026. doi:10.1111/ene.70499
BibTeX
@article{Frachet2026,
author = {Frachet, Simon and Soust, Emilie and Richard, Laurence and Danigo, Aurore and Demiot, Claire and Magy, Laurent},
title = {Screening Value of the I‐Douleur Neuropathique 4 Questionnaire for Small Fibre Neuropathy in Patients With Painful Syndromes: Insights From 872 Skin Biopsies},
journal = {European Journal of Neurology},
year = {2026},
doi = {10.1111/ene.70499}
}
EUVIMED